Neural development is a complex process through which the nervous system, including the brain and spinal cord, evolves from its earliest stages to its fully functional state. This developmental journey involves several stages, beginning with neural induction, where embryonic cells are directed to become neural cells. Subsequent phases include neural proliferation, migration, and neurite outgrowth, where neurons multiply, move to designated locations, and form connections called synapses. Synaptic pruning then refines these connections, eliminating unnecessary ones while strengthening important ones crucial for learning and memory formation. Molecular signals such as neurotransmitters and growth factors play vital roles in guiding neural development, and disruptions in these pathways can lead to developmental disorders like autism spectrum disorder. Neural development isn't confined to early embryonic stages; it continues throughout life via processes like neurogenesis and synaptic plasticity. Neurogenesis involves the formation of new neurons, particularly in regions associated with learning and memory, while synaptic plasticity refers to the brain's ability to adapt and reorganize connections in response to experiences. Understanding neural development is essential for unraveling brain function mechanisms, developing treatments for neurological disorders, and optimizing strategies for learning and cognitive enhancement, highlighting its significance in both basic neuroscience research and clinical applications.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States